REMA ZEBDA to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications REMA ZEBDA has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.127
-
Phosphodiesterase 4 inhibitors. J Am Acad Dermatol. 2018 03; 78(3 Suppl 1):S43-S52.
Score: 0.127
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.